The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1765, Issue 2, 2006, Pages 85-100

  Carpenter, Brian ^a,b   MacKay, Catriona ^b   Alnabulsi, Ayham ^b   MacKay, Morven ^a   Telfer, Colin ^b   Melvin, William T ^b   Murray, Graeme I ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Auvation Limited   (United Kingdom)

Author keywords

Cellular function; Diagnosis; Gene expression; Heterogeneous nuclear ribonucleoproteins; Neoplasm; Structure; Treatment; Tumour

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; RIBONUCLEOPROTEIN;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; APOPTOSIS; BIOGENESIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL INVASION; CLINICAL TRIAL; DNA REPAIR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RNA SPLICING; RNA STABILITY; RNA TRANSLATION; SIGNAL TRANSDUCTION; TELOMERE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE PROGRESSION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 33646132293     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2005.10.002     Document Type: Review

References (161)

1. Choi Y.D., and Dreyfuss G. Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): a unique supramolecular assembly. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 7471-7475
2. Pinol-Roma S., Choi Y.D., Matunis M.J., and Dreyfuss G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev. 2 (1988) 215-227
3. Dreyfuss G., Matunis M.J., Pinol-Roma S., and Burd G.G. HnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62 (1993) 289-321
4. Saccone S., Biamonti G., Maugeri S., Bassi M.T., Bunone G., Riva S., and Della Valle G. Assignment of the human heterogeneous nuclear ribonucleoprotein A1 gene (hnRNP A1) to chromosome 12q13.1 by cDNA competitive in situ hybridization. Genomics 12 (1992) 171-174
5. Biamonti G., Buvoli M., Bassi M.T., Morandi C., Cobianchi F., and Riva S. Isolation of an active gene encoding human hnRNP protein A1. Evidence for alternative splicing. J. Mol. Biol. 207 (1989) 491-503
6. Buvoli M., Biamonti G., Tsoulfas P., Bassi M.T., Ghetti A., Riva S., and Morandi C. cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res. 16 (1988) 3751-3770
7. Biamonti G., Ruggiu M., Saccone S., Della Valle G., and Riva S. Two homologous genes, originated by duplication, encode the human hnRNP proteins A2 and A1. Nucleic Acids Res. 22 (1994) 1996-2002
8. Burd C.G., Swanson M.S., Gorlach M., and Dreyfuss G. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts. Proc. Natl. Acad. Sci U. S. A. 86 (1989) 9788-9792
9. Swanson M.S., Nakagawa T.Y., LeVan K., and Dreyfuss G. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol. Cell. Biol. 7 (1987) 1731-1739
10. Dempsey L.A., Li M.J., DePace A., Bray-Ward P., and Maizels N. The human HNRPD locus maps to 4q21 and encodes a highly conserved protein. Genomics 49 (1998) 378-384
11. Wagner B.J., DeMaria C.T., SuN Y., Wilson G.M., and Brewer G. Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics 48 (1998) 195-202
12. Makeyev A.V., Chkheidze A.N., and Liebhaber S.A. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J. Biol. Chem. 274 (1999) 24849-24857
13. Honore B., Rasmussen H.H., Vorum H., Dejgaard K., Liu X., Gromov P., Madsen P., Gesser B., Tommerup N., and Celis J.E. Heterogeneous nuclear ribonucleoproteins H, H′, and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes. J. Biol. Chem. 270 (1995) 28780-28789
14. Soulard M., Valle V.D., Siomi M.C., Piñol-Roma S., Codogno P., Bauvy C., Bellini M., Lacroix J.C., Monod G., and Dreyfuss G. HnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res. 21 (1993) 4210-4217
15. Romanelli M.G., Lorenzi P., and Morandi C. Organization of the human gene encoding heterogeneous nuclear ribonucleoprotein type I (hnRNP I) and characterization of hnRNP I related pseudogene. Gene 255 (2000) 267-272
16. Patton J.G., Mayer S.A., Tempst P., and Nadal-Ginard B. Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev. 5 (1991) 1237-1251
17. Ghetti A., Pinol-Roma S., Michael W.M., Morandi C., and Dreyfuss G. HnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 20 (1992) 3671-3678
18. Mahe D., Mahl P., Gattoni R., Fischer N., Mattei M.G., Stevenin J., and Fuchs J.P. Cloning of human 2H9 heterogeneous nuclear ribonucleoproteins. Relation with splicing and early heat shock-induced splicing arrest. J. Biol. Chem. 272 (1997) 1827-1836
19. Honore B. The hnRNP 2H9 gene, which is involved in the splicing reaction, is a multiply spliced gene. Biochim. Biophys. Acta 1492 (2000) 108-119
20. Dejgaard K., Leffers H., Rasmussen H.H., Madsen P., Kruse T.A., Gesser B., Nielsen H., and Celis J.E. Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing. J. Mol. Biol. 236 (1994) 33-48
21. Pinol-Roma S., Swanson M.S., Gall J.G., and Dreyfuss G. A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts. J. Cell. Biol. 109 (1989) 2575-2587
22. Blanck O., Perrin C., Mziaut H., Darbon H., Mattei M.G., and Miquelis R. Molecular cloning, cDNA analysis, and localization of a monomer of the N-acetylglucosamine-specific receptor of the thyroid, NAGR1, to chromosome 19p13.3-13.2. Genomics 21 (1994) 18-26
23. Gattoni R., Mahe D., Mahl P., Fischer N., Mattei M.G., Stevenin J., and Fuchs J.P. The human hnRNP-M proteins: structure and relation with early heat shock-induced splicing arrest and chromosome mapping. Nucleic Acids Res. 24 (1996) 2535-2542
24. Datar K.V., Dreyfuss G., and Swanson M.S. The human hnRNP M proteins: identification of a methionine/arginine-rich repeat motif in ribonucleoproteins. Nucleic Acids Res. 21 (1993) 439-446
25. Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., and Ohki M. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene 221 (1998) 191-198
26. Mourelatos Z., Abel L., Yong J., Kataoka N., and Dreyfuss G. SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20 (2001) 5443-5452
27. Hassfeld W., Chan E.K., Mathison D.A., Portman D., Dreyfuss G., Steiner G., and Tan E.M. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P. Nucleic Acids Res. 26 (1998) 439-445
28. Fackelmayer F.O., and Richter A. Purification of two isoforms of hnRNP-U and characterization of their nucleic acid binding activity. Biochemistry 33 (1994) 10416-10422
29. Dang C.V. C-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19 (1999) 1-11
30. Grandori C., Cowley S.M., James L.P., and Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell. Dev. Biol. 16 (2000) 653-699
31. http://www.cbil.upenn.edu/cgi-bin/tess/tess?RQ=SEA-FR-QueryS.
32. http://bioportal.bic.nus.edu.sg/tres/.
33. http://www.cbrc.jp.research/db/TFSEARCH.html.
34. Pandolfo M., Valentini O., Biamonti G., Morandi C., and Riva S. Single stranded DNA binding proteins derive from hnRNP proteins by proteolysis in mammalian cells. Nucleic Acids Res. 13 (1985) 6577-6590
35. Hay D.C., Kemp G.D., Dargemont C., and Hay R.T. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol. Cell. Biol. 10 (2001) 3482-3490
36. Iwanaga K., Sueoka N., Sato A., Hayashi S., and Sueoka F. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity. Biochem. Biophys. Res. Commun. 333 (2005) 888-895
37. Smith G.C., and Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 13 (1999) 916-934
38. Lee S.Y., Park J.H., Kim S., Park E.J., Yun Y., and Kwon J. A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks. Biochem. J. 388 (2005) 7-15
39. Zhang S., Schlott B., Gorlach M., and Grosse F. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucleic Acids Res. 32 (2004) 1-10
40. Ford L.P., Wright W.E., and Shay J.W. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 21 (2002) 580-583
41. Eversole A., and Maizels N. In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol. Cell. Biol. 20 (2000) 5425-5432
42. Kamma H., Fujimoto M., Fujiwara M., Matsui M., Horiguchi H., Hamasaki M., and Satoh H. Interaction of hnRNP A2/B1 isoforms with telomeric ssDNA and the in vitro function. Biochem. Biophys. Res. Commun. 280 (2001) 625-630
43. Ishikawa F., Matunis M.J., Dreyfuss G., and Cech T.R. Nuclear proteins that bind the pre-mRNA 3′ splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n. Mol. Cell. Biol. 13 (1993) 4301-4310
44. LaBranche H., Dupuis S., Ben-David Y., Bani M.R., Wellinger R.J., and Chabot B. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat. Genet. 19 (1998) 199-202
45. Moran-Jones K., Wayman L., Kennedy D.D., Reddel R.R., Sara S., Snee M.J., and Smith R. HnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res. 33 (2005) 486-496
46. Kouzarides T. Wellcome trust award lecture. Chromatin-modifying enzymes in transcription and cancer. Biochem. Soc. Trans. 31 (2003) 741-743
47. Gohring F., and Fackelmayer F.O. The scaffold/matrix attachment region binding protein hnRNP-U (SAF-A) is directly bound to chromosomal DNA in vivo: a chemical cross-linking study. Biochemistry 36 (1997) 8276-8283
48. Martens J.H., Verlaan M., Kalkhoven E., Dorsman J.C., and Zantema A. Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol. Cell. Biol. 22 (2002) 2598-2606
49. Shnyreva M., Schullery D.S., Suzuki H., Higaki Y., and Bomsztyk K. Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein. J. Biol. Chem. 275 (2000) 15498-15503
50. Ritchie S.A., Pasha M.K., Batten D.J., Sharma R.K., Olson D.J., Ross A.R., and Bonham K. Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. Nucleic Acids Res. 31 (2003) 1502-1513
51. Michelotti E.F., Michelotti G.A., Aronsohn A.I., and Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol. Cell. Biol. 16 (1996) 2350-2360
52. Ostrowski J., Kawata Y., Schullery D.S., Denisenko O.N., and Bomsztyk K. Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acids Res. 31 (2003) 3954-3962
53. Lee M.H., Mori S., and Raychaudhuri P. Trans-Activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes. J. Biol. Chem. 271 (1996) 3420-3437
54. Miau L.H., Chang C.J., Shen B.J., Tsai W.H., and Lee S.C. Identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a repressor of C/EBPbeta-mediated gene activation. J. Biol. Chem. 273 (1998) 10784-10791
55. Kim M.K., and Nikodem V.M. HnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation. Mol. Cell. Biol. 19 (1999) 6833-6844
56. Kukalev A., Nord Y., Palmberg C., Bergman T., and Percipalle P. Actin and hnRNP U cooperate for productive transcription by RNA polymerase II. Nat. Struct. Mol. Biol. 12 (2005) 238-244
57. Chansky H.A., Hu M., Hickstein D.D., and Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 61 (2001) 3586-3590
58. Tolnay M., Juang Y.T., and Tsokos G.C. Protein kinase A enhances, whereas glycogen synthase kinase-3 beta inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashion. Biochem. J. 63 (2002) 127-136
59. Fuentes-Panana E.M., Peng R., Brewer G., Tan J., and Ling P.D. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J. Virol. 74 (2000) 8166-8175
60. Vassileva M.T., and Matunis M.J. SUMO modification of heterogeneous nuclear ribonucleoproteins. Mol. Cell. Biol. 24 (2004) 3623-3632
61. Proudfoot N., and O'Sullivan J. Polyadenylation: a tail of two complexes. Curr. Biol. 12 (2002) R855-R857
62. Bagga P.S., Arhin G.K., and Wilusz J. DSEF-1 is a member of the hnRNP H family of RNA-binding proteins and stimulates pre-mRNA cleavage and polyadenylation in vitro. Nucleic Acids Res. 26 (1998) 5343-5350
63. Veraldi K.L., Arhin G.K., Martincic K., Chung-Ganster L.H., Wilusz J., and Milcarek C. HnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol. Cell. Biol. 21 (2001) 1228-1238
64. Moreira A., Takagaki Y., Brackenridge S., Wollerton M., Manley J.L., and Proudfoot N.J. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3′ end formation by two distinct mechanisms. Genes Dev. 12 (1998) 2522-2534
65. Castelo-Branco P., Furger A., Wollerton M., Smith C., Moreira A., and Proudfoot N. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol. Cell. Biol. 24 (2004) 4174-4183
66. Sharma S., Falick A.M., and Black B.L. Polypyrimidine tract binding protein blocks the 5′ splice site-dependent assembly of U2AF and the prespliceosomal E complex. Mol. Cell. 19 (2005) 485-496
67. Audic Y., and Hartley R.S. Post-transcriptional regulation in cancer. Biol. Cell. 96 (2004) 479-498
68. Bevilacqua A., Ceriani M.C., Capaccioli S., and Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. J. Cell. Physiol. 195 (2003) 356-372
69. Brewer G. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11 (1991) 2460-2466
70. DeMaria C.T., and Brewer G. AUF1 binding affinity to A + U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271 (1996) 12179-12184
71. Sirenko O.I., Lofquist A.K., DeMaria C.T., Morris J.S., Brewer G., and Haskill J.S. Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol. Cell. Biol. 17 (1997) 3898-3906
72. Loflin P., Chen C.Y., and Shyu A.B. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13 (1999) 1884-1897
73. Kiledjian M., DeMaria C.T., Brewer G., and Novick K. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol. Cell. Biol. 17 (1997) 4870-4876
74. Wang Z., Day N., Trifillis P., and Kiledjian M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol. Cell. Biol. 19 (1999) 4552-4560
75. Kong J., Ji X., and Liebhaber S.A. The KH-domain protein alpha CP has a direct role in mRNA stabilization independent of its cognate binding site. Mol. Cell. Biol. 23 (2003) 1125-1134
76. Xu N., Chen C.Y., and Shyu A.B. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell. Biol. 20 (2001) 6960-6971
77. Venables J.P. Aberrant and alternative splicing in cancer. Cancer Res. 64 (2004) 7647-7654
78. Kalnina Z., Zayakin P., Silina K., and Line A. Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42 (2005) 342-357
79. Rooke N., Markovtsov V., Cagavi E., and Black D.L. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1. Mol. Cell. Biol. 23 (2003) 1874-1884
80. Caceres J.F., and Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18 (2002) 186-193
81. Zerbe L.K., Pino I., Pio R., Cosper P.F., Dwyer-Nield L.D., Meyer A.M., Port J.D., Montuenga L.M., and Malkinson A.M. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing. Mol. Carcinog. 41 (2004) 187-196
82. Mercatante D., and Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol. Ther. 85 (2000) 237-243
83. Matter N., Marx M., Weg-Remers S., Ponta H., Herrlich P., and Konig H. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J. Biol. Chem. 275 (2000) 35353-35360
84. Galiana-Arnoux D., Lejeune F., Gesnel M.C., Stevenin J., Breathnach R., and Del Gatto-Konczak F. The CD44 alternative V9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J. Biol. Chem. 278 (2003) 32943-32953
85. Min H., Chan R.C., and Black D.L. The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event. Genes Dev. 9 (1995) 2659-2671
86. Chou M.Y., Rooke N., Turck C.W., and Black D.L. HnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol. Cell. Biol. 19 (1999) 69-77
87. Bothwell A.L., Ballard D.W., Philbrick W.M., Lindwall G., Maher S.E., Bridgett M.M., Jamison S.F., and Garcia-Blanco M.A. Murine polypyrimidine tract binding protein. Purification, cloning, and mapping of the RNA binding domain. J. Biol. Chem. 266 (1991) 24657-24663
88. Mulligan G.J., Guo W., Wormsley S., and Helfman D.M. Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of beta-tropomyosin pre-mRNA. J. Biol. Chem. 267 (1992) 25480-25487
89. Chou M.Y., Underwood J.G., Nikolic J., Luu M.H., and Black D.L. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell 5 (2000) 949-957
90. Southby J., Gooding C., and Smith C.W. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actin in mutally exclusive exons. Mol. Cell. Biol. 19 (1999) 2699-2711
91. Wollerton M.C., Gooding C., Wagner E.J., Garcia-Blanco M.A., and Smith C.W. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13 (2004) 91-100
92. Xie J., Lee J.A., Kress T.L., Mowry K.L., and Black D.L. Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8776-8781
93. Siomi H., and Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J. Cell. Biol. 129 (1995) 551-560
94. Michael W.M., Choi M., and Dreyfuss G. Nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell 3 (1995) 415-422
95. van der Houven van Oordt W., Diaz-Meco M.T., Lozano J., Krainer A.R., Moscat J., and Caceres J.F. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell. Biol. 149 (2000) 307-316
96. Vautier D., Chesne P., Cunha C., Calado A., Renard J.P., and Carmo-Fonseca M. Transcription-dependent nucleocytoplasmic distribution of hnRNP A1 protein in early mouse embryos. J. Cell. Sci. 114 (2001) 1521-1531
97. Iervolino A., Santilli G., Trotta R., Guerzoni C., Cesi V., Bergamaschi A., Gambacorti-Passerini C., Calabretta B., and Perrotti D. HnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis. Mol. Cell. Biol. 27 (2002) 2255-2266
98. Pinol-Roma S. HnRNP proteins and the nuclear export of mRNA. Semin. Cell Dev. Biol. 8 (1997) 57-63
99. Kim J.H., Paek K.Y., Choi K., Kim T.D., Hahm B., Kim K.T., and Jang S.K. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol. Cell. Biol. 23 (2003) 708-720
100. Evans J.R., Mitchell S.A., Spriggs K.A., Ostrowski J., Bomsztyk K., Ostarek D., and Willis A.E. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22 (2003) 8012-8020
101. Pickering B.M., Mitchell S.A., Spriggs K.A., Stoneley M., and Willis A.E. Bag-1 internal ribosome entry segment activity is promoted by structural changes mediated by poly(rC) binding protein 1 and recruitment of polypyrimidine tract binding protein 1. Mol. Cell. Biol. 24 (2004) 5595-5605
102. Touriol C., Bornes S., Bonnal S., Audigier S., Prats H., Prats A.C., and Vagner S. Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons. Biol. Cell. 95 (2003) 169-178
103. Bonnal S., Pileur F., Orsini C., Parker F., Pujol F., Prats A.C., and Vagner S. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J. Biol. Chem. 280 (2005) 4144-4153
104. Bikfalvi A., Klein S., Pintucci G., and Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18 (1997) 26-45
105. Ostareck D.H., Ostareck-Lederer A., Wilm M., Thiele B.J., Mann M., and Hentze M.W. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89 (1997) 597-606
106. Bast Jr. R.C., Ravdin P., Hayes D.F., Bates S., Fritsche Jr. H., Jessup J.M., Kemeny N., Locker G.Y., Mennel R.G., and Somerfield M.R. American Society of Clinical Oncology Tumor Markers Expert Panel, 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19 (2001) 1865-1878
107. Bajenova O.V., Zimmer R., Stolper E., Salisbury-Rowswell J., Nanji A., and Thomas P. Heterogeneous RNA-binding protein M4 is a receptor for carcinoembryonic antigen in Kupffer cells. J. Biol. Chem. 276 (2001) 31067-31073
108. Laguinge L., Bajenova O., Bowden E., Sayyah J., Thomas P., and Juhl H. Surface expression and CEA binding of hnRNP M4 protein in HT29 colon cancer cells. Anticancer Res. 25 (2005) 23-31
109. Iko Y., Kodama T.S., Kasai N., Oyama T., Morita E.H., Muto T., Okumura M., Fujii R., Takumi T., Tate S., and Morikawa K. Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 279 (2004) 44834-44840
110. Aman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willen H., Rydholm A., and Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5 (1992) 278-285
111. Ron D., and Habener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6 (1992) 439-453
112. Barone M.V., Crozat A., Tabaee A., Philipson L., and Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8 (1994) 453-464
113. Ubeda M., Wang X.Z., Zinszner H., Wu I., Habener J.F., and Ron D. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol. Cell. Biol. 16 (1996) 1479-1489
114. Batchvarova N., Wang X.Z., and Ron D. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14 (1995) 4654-4661
115. Coutts M., Cui K., Davis K.L., Keutzer J.C., and Sytkowski A.J. Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation. Blood 93 (1999) 3369-3378
116. Zinszner H., Albalat R., and Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 8 (1994) 2513-2526
117. Ichikawa H., Shimizu H., Hayashi Y., and Ohki M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res. 54 (1994) 2865-2868
118. Prasad D.D., Ouchida M., Lee L., Rao V.N., and Reddy E.S. TLS/FUS fusion domain of TLS/FUS-ERG chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9 (1994) 3717-3729
119. Ichikawa H., Shimizu K., Katsu R., and Ohki M. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol. Cell. Biol. 19 (1999) 7639-7650
120. He Y., Brown M.A., Rothnagel J.A., Saunders N.A., and Smith R. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J. Cell. Sci. 118 (2005) 3173-3183
121. Gouble A., Grazide S., Meggetto F., Mercier P., Delsol G., and Morello D. A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res. 62 (2002) 1489-1495
122. Zhu J., and Chen X. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M. Mol. Cell. Biol. 20 (2000) 5602-5618
123. Pio R., Zudaire I., Pino I., Castano Z., Zabalegui N., Vicent S., Garcia-Amigot F., Odero M.D., Lozano M.D., Garcia-Foncillas J., Calasanz M.J., and Montuenga L.M. Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer. Cancer Res. 64 (2004) 4171-4179
124. Lynch M., Chen L., Ravitz M.J., Mehtani S., Korenblat K., Pazin M.J., and Schmidt E.V. HnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol. Cell. Biol. 25 (2005) 6436-6453
125. Barral P.M., Rusch A., Turnell A.S., Gallimore P.H., Byrd P.J., Dobner T., and Grand R.J. The interaction of the hnRNP family member E1B-AP5 with p53. FEBS Lett. 579 (2005) 2752-2758
126. Reed J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17 (1999) 2941-2953
127. Ionov Y., Yamamoto H., Krajewski S., Reed J.C., and Perucho M. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10872-10877
128. Holcik M., Gordon B.W., and Korneluk R.G. The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol. Cell. Biol. 23 (2003) 280-288
129. Garneau D., Revil T., Fisette J.F., and Chabot B. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 280 (2005) 22641-22650
130. de Hoog C.L., Foster L.J., and Mann M. RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers. Cell 117 (2004) 649-662
131. Nyberg P., Xie L., and Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 65 (2005) 3967-3979
132. Shih S.C., and Claffey K.P. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem. 274 (1999) 1359-1365
133. Tockman M.S., Gupta P.K., Myers J.D., Frost J.K., Baylin S.B., Gold E.B., Chase A.M., Wilkinson P.H., and Mulshine J.L. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol. 6 (1988) 1685-1693
134. Mulshine J.L., Cuttitta F., Bibro M., Fedorko J., Fargion S., Little C., Carney D.N., Gazdar A.F., and Minna J.D. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J. Immunol. 131 (1983) 497-502
135. Zhou J., Mulshine J.L., Unsworth E.J., Scott F.M., Avis I.M., Vos M.D., and Treston A.M. Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J. Biol. Chem. 271 (1996) 10760-10766
136. Wu S., Sato M., Endo C., Sakurada A., Dong B., Aikawa H., Chen Y., Okada Y., Matsumura Y., Sueoka E., and Kondo T. HnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 41 (2003) 179-186
137. Snead D.R., Perunovic B., Cullen N., Needham M., Dhillon D.P., Satoh H., and Kamma H. HnRNP B1 expression in benign and malignant lung disease. J. Pathol. 200 (2003) 88-94
138. Sueoka E., Sueoka N., Goto Y., Matsuyama S., Nishimura H., Sato M., Fujimura S., Chiba H., and Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res. 61 (2001) 1896-1902
139. Tominaga M., Sueoka N., Irie K., Iwanaga K., Tokunaga O., Hayashi S., Nakachi K., and Sueoka E. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67. Lung Cancer 40 (2003) 45-53
140. Man Y.G., Martinez A., Avis I.M., Hong S.H., Cuttitta F., Venzon D.J., and Mulshine J.L. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am. J. Respir. Cell Mol. Biol. 23 (2000) 636-645
141. Zhou J., Nong L., Wloch M., Cantor A., Mulshine J.L., and Tockman M.S. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer 34 (2001) 341-350
142. Tockman M.S., Mulshine J.L., Piantadosi S., Erozan Y.S., Gupta P.K., Ruckdeschel J.C., Taylor P.R., Zhukov T., Zhou W.H., Qiao Y.L., and Yao S.X. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res. 3 (1997) 2237-2246
143. Qiao Y.L., Tockman M.S., Li L., Erozan Y.S., Yao S.X., Barrett M.J., Zhou W.H., Giffen C.A., Luo X.C., and Taylor P.R. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China. Cancer Epidemiol., Biomarkers Prev. 6 (1997) 893-900
144. Pino I., Pio R., Toledo G., Zabalegui N., Vicent S., Rey N., Lozano M.D., Torre W., Garcia-Foncillas J., and Montuenga L.M. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 41 (2003) 131-143
145. Ushigome M., Ubagai T., Fukuda H., Tsuchiya N., Sugimura T., Takatsuka J., and Nakagama H. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int. J. Oncol. 26 (2005) 635-640
146. Zhou J., Allred D.C., Avis I., Martinez A., Vos M.D., Smith L., Treston A.M., and Mulshine J.L. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res. Treat. 66 (2001) 217-224
147. Yan-Sanders Y., Hammons G.J., and Lyn-Cook B.D. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett. 183 (2002) 215-220
148. Lee C.H., Lum J.H., Cheung B.P., Wong M.S., Butt Y.K., Tam M.F., Chan W.Y., Chow C., Hui P.K., Kwok F.S., Lo S.C., and Fan D.M. Identification of the heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for the gastrointestinal cancer specific monoclonal antibody MG7. Proteomics 5 (2005) 1160-1166
149. Bidot P., Morgan M., Zhukov T., Tannenbaum M., and Tockman M.S. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. Endocr. Pract. 7 (2001) 157-161
150. Matsuyama S., Goto Y., Sueoka N., Ohkura Y., Tanaka Y., Nakachi K., and Sueoka E. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn. J. Cancer Res. 91 (2000) 658-663
151. Tani H., Ohshima K., Haraoka S., Hamasaki M., Kamma H., Ikeda S., and Kikuchi M. Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin. Int. J. Oncol. 21 (2002) 957-963
152. Tani H., Ohshima K., Haraoka S., Hamasaki M., Kamma H., Ikeda S., and Kikuchi M. Reduced expression of heterogeneous nuclear ribonucleoprotein B1 in adult T-cell lymphoma/leukemia. Int. J. Oncol. 22 (2003) 529-534
153. Goto Y., Sueoka F., Chiba H., and Fujiki H. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn. J. Cancer Res. 90 (1999) 1358-1363
154. Pillai M.R., Chacko P., Kesari L.A., Jayaprakash P.G., Jayaram H.N., and Antony A.C. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J. Clin. Pathol. 56 (2003) 569-574
155. Honore B., Baandrup U., and Vorum H. Heterogeneous nuclear ribonucleoproteins F and H/H′ show differential expression in normal and selected cancer tissues. Exp. Cell. Res. 294 (2004) 199-209
156. Rauch J., Ahlemann M., Schaffrik M., Mack B., Ertongur S., Andratschke M., Zeidler R., Lang S., and Gires O. Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem. Biophys. Res. Commun. 323 (2004) 156-162
157. Jin W., McCutcheon I.E., Fuller G.N., Huang E.S., and Cote G.J. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res. 60 (2000) 1221-1224
158. Ostrowski J., and Bomsztyk K. Nuclear shift of hnRNP K protein in neoplasms and other states of enhanced cell proliferation. Br. J. Cancer 89 (2003) 1493-1501
159. Nagano K., Masters J.R., Akpan A., Yang A., Corless S., Wood C., Hastie C., Zvelebil M., Cramer R., and Naaby-Hansen S. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons. Oncogene 23 (2004) 1693-1703
160. Blaxall B.C., Dwyer-Nield L.D., Bauer A.K., Bohlmeyer T.J., Malkinson A.M., and Port J.D. Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog. 28 (2000) 76-83
161. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117